Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Current concepts in the treatment of epidermolysis bullosa acquisita.

Gürcan HM, Ahmed AR.

Expert Opin Pharmacother. 2011 Jun;12(8):1259-68. doi: 10.1517/14656566.2011.549127. Epub 2011 Jan 22. Review.

PMID:
21254861
2.

Emerging treatment for epidermolysis bullosa acquisita.

Engineer L, Ahmed AR.

J Am Acad Dermatol. 2001 May;44(5):818-28. Review.

PMID:
11312431
3.

Management of epidermolysis bullosa acquisita.

Intong LR, Murrell DF.

Dermatol Clin. 2011 Oct;29(4):643-7. doi: 10.1016/j.det.2011.06.020. Epub 2011 Aug 15. Review.

PMID:
21925011
4.

Remission of severe epidermolysis bullosa acquisita induced by extracorporeal photochemotherapy.

Miller JL, Stricklin GP, Fine JD, King LE, Arzubiaga MC, Ellis DL.

Br J Dermatol. 1995 Sep;133(3):467-71.

PMID:
8547007
5.

The successful use of extracorporeal photopheresis in a 12-year-old patient with refractory epidermolysis bullosa acquisita.

Liszewski W, Omland SH, Gniadecki R.

Pediatr Dermatol. 2015 Mar-Apr;32(2):e60-1. doi: 10.1111/pde.12526. Epub 2015 Jan 30.

PMID:
25639865
6.

Successful treatment of epidermolysis bullosa acquisita using intravenous immunoglobulins.

Mohr C, Sunderkötter C, Hildebrand A, Biel K, Rütter A, Rütter GH, Luger TA, Kolde G.

Br J Dermatol. 1995 May;132(5):824-6.

PMID:
7772494
7.

Epidermolysis bullosa acquisita: efficacy of high-dose intravenous immunoglobulins.

Meier F, Sönnichsen K, Schaumburg-Lever G, Dopfer R, Rassner G.

J Am Acad Dermatol. 1993 Aug;29(2 Pt 2):334-7.

PMID:
8340508
8.

[Epidermolysis bullosa acquisita: literature review].

Le Roux-Villet C, Prost-Squarcioni C.

Ann Dermatol Venereol. 2011 Mar;138(3):228-46. doi: 10.1016/j.annder.2011.01.019. Epub 2011 Feb 24. Review. French.

PMID:
21397153
9.

Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: clinical outcome and post-treatment long-term follow-up.

Ahmed AR, Gürcan HM.

J Eur Acad Dermatol Venereol. 2012 Sep;26(9):1074-83. doi: 10.1111/j.1468-3083.2011.04205.x. Epub 2011 Aug 8.

PMID:
21819451
10.

Intravenous immunoglobulin treatment in therapy-resistant epidermolysis bullosa acquisita.

Kofler H, Wambacher-Gasser B, Topar G, Weinlich G, Schuler G, Hintner H, Romani N, Fritsch P.

J Am Acad Dermatol. 1997 Feb;36(2 Pt 2):331-5.

PMID:
9039213
11.

Remission of severe autoimmune bullous disorders induced by long-term extracorporeal photochemotherapy.

Sanli H, Akay BN, Ayyildiz E, Anadolu R, Ilhan O.

Transfus Apher Sci. 2010 Dec;43(3):353-9. doi: 10.1016/j.transci.2010.10.006. Epub 2010 Oct 28.

PMID:
21035398
12.

[Epidermolysis bullosa acquisita. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].

Prost-Squarcioni C, Ingen-Housz-Oro S, Joly P, Bernard P, Bedane C; Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie.

Ann Dermatol Venereol. 2011 Mar;138(3):274-9. doi: 10.1016/j.annder.2011.01.013. Epub 2011 Feb 18. French. No abstract available.

PMID:
21397160
13.

Mycophenolate mofetil in epidermolysis bullosa acquisita.

Kowalzick L, Suckow S, Ziegler H, Waldmann T, Pönnighaus JM, Gläser V.

Dermatology. 2003;207(3):332-4. No abstract available.

PMID:
14571084
14.

Long-term results of rituximab-intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy.

Oktem A, Akay BN, Boyvat A, Kundakci N, Erdem C, Bostancı S, Sanli H, Kocyigit P.

J Dermatolog Treat. 2017 Feb;28(1):50-54. doi: 10.1080/09546634.2016.1179711. Epub 2016 May 10.

PMID:
27161164
15.

Remission of recalcitrant epidermolysis bullosa acquisita (EBA) with colchicine monotherapy.

Arora KP, Sachdeva B, Singh N, Bhattacharya SN.

J Dermatol. 2005 Feb;32(2):114-9.

PMID:
15906541
16.

Long-term efficacy of extracorporeal photochemotherapy in a patient with refractory epidermolysis bullosa acquisita.

Baroudjian B, Le Roux-Villet C, Bréchignac S, Alexandre M, Caux F, Prost-Squarcioni C, Laroche L.

Eur J Dermatol. 2012 Nov-Dec;22(6):795-7. doi: 10.1684/ejd.2012.1840. No abstract available.

PMID:
23228865
17.

Premonitory epidermolysis bullosa acquisita mimicking eyelid dermatitis: successful treatment with rituximab and protein A immunoapheresis.

Kubisch I, Diessenbacher P, Schmidt E, Gollnick H, Leverkus M.

Am J Clin Dermatol. 2010;11(4):289-93. doi: 10.2165/11533210-000000000-00000.

PMID:
20373827
18.

Treatment of epidermolysis bullosa acquisita with the humanized anti-Tac mAb daclizumab.

Egan CA, Brown M, White JD, Yancey KB.

Clin Immunol. 2001 Nov;101(2):146-51.

PMID:
11683573
19.

Epidermolysis bullosa acquisita: diagnosis by fluorescence overlay antigen mapping and clinical response to high-dose intravenous immunoglobulin.

Campos M, Silvente C, Lecona M, Suárez R, Lázaro P.

Clin Exp Dermatol. 2006 Jan;31(1):71-3.

PMID:
16309488
20.

Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy.

Gordon KB, Chan LS, Woodley DT.

Br J Dermatol. 1997 Mar;136(3):415-20.

PMID:
9115929

Supplemental Content

Support Center